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ABSTRACT
Introduction Non- communicable diseases (NCDs) 
are associated with lower health- related quality of life 
(HRQoL). However, knowledge about those diseases and 
predictors with a greater impact on patients’ HRQoL as 
well as knowledge on the complex relationship between 
HRQoL and comorbidities is lacking. The aim of this study 
is to assess the impact of NCDs on patients’ HRQoL, with a 
focus on multimorbidity and socioeconomic status.
Methods and analysis A primary care- based cross- 
sectional study is conducted in Flanders (Belgium). Study 
participants (≥18 years) are medically diagnosed with 
at least one of the following diseases: cardiometabolic 
disorders, mental disorders and musculoskeletal disorders. 
A minimum of 50 general practitioners will participate to 
recruit participants (convenient sample) and a total of 531 
patients will be enrolled (voluntary response sample). Each 
participant will complete a paper- based questionnaire 
to gather research outcomes. Statistical analyses will be 
performed using multiple linear regression models with 
HRQoL as main outcome parameter, adjusted for possible 
confounders. This study will generate new evidence on 
the key predictors of HRQoL in patients with NCDs, and 
particularly provide new insights in multimorbidity to 
improve the quality of care in primary care, to support 
patients’ self- management and to allocate resources more 
effectively.
Ethics and dissemination The study has been approved 
by the Ethical Committee of Ghent University Hospital, 
Ghent, Belgium (reference number: B670201939629) prior 
to the beginning of the recruitment. Study results will be 
disseminated through peer- reviewed publications and 
conference presentations.
INTRODUCTION
Non- communicable diseases (NCDs) remain 
the leading cause of morbidity and mortality 
worldwide, responsible for 36 million deaths 
annually, with a rapidly rising prevalence due 
to population growth and ageing.1 2 Further-
more, chronically ill patients often suffer 
from multimorbidity, which can be defined as 
the co- occurrence of several chronic condi-
tions within one person. Depending on the 
age class, multimorbidity occurs in 13%–72% 
of the general population worldwide.3 In 
2018, 15% of the Belgian population aged 
15 years and older suffered from multimor-
bidity and this percentage increased strongly 
with age, going up to 42% for people aged 75 
years and older.4
NCDs are associated with a substantial 
burden of disease for the patients, their care-
givers and the society as a whole.5 6 During 
the past decades, the interest into chron-
ically ill patients’ health- related quality of life 
(HRQoL) as a key health outcome indicator 
is growing due to the absence of an adequate 
cure for several NCDs, resulting in a shift 
from problem- oriented care to goal- oriented 
care.2 Many studies revealed a significant 
decrease in HRQoL in patients with NCD and 
indicated HRQoL as an important predictor 
of morbidity and mortality.7 8
While numerous studies have addressed 
the impact of single NCDs on HRQoL, a 
thorough understanding of the influence 
of several predictors and risk indicators (eg, 
socioeconomic status) is lacking. Additionally, 
little is known about the impact of multimor-
bidity on HRQoL outcomes as most studies 
focus on one particular disease. Although 
an inverse relationship is seen between the 
number of NCDs and HRQoL, a simple count 
of the number of NCDs does not completely 
Strengths and limitations of this study
 ► This study will improve the understanding of the key 
predictors of self- perceived health status in patients 
with non- communicable disease and multimorbidity 
in a primary care setting.
 ► Data are collected through a paper- based question-
naire consisting of diverse validated instruments.
 ► This study uses objective medical diagnoses ob-
tained via general practitioners, limiting the risk of 
self- reported bias.
 ► Participants are recruited through voluntary re-
sponse sample which potentially introduces selec-
tion bias.
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capture the association between both.9 When the outcome 
of interest is HRQoL, looking at clusters of specific NCDs 
has been explored by previous research, however, this 
association needs to be further investigated.10 11
To date, research on NCDs and multimorbidity usually 
focuses on the elderly population, resulting in insuffi-
cient knowledge on HRQoL in younger populations.12 
Some studies however indicated an increased level of 
mental problems among younger populations groups, 
but the impact is not fully known.13 Moreover, the impact 
on HRQoL is often measured by one specific instrument, 
albeit disease- specific or not, while meaningful infor-
mation could be obtained by capturing HRQoL from 
multiple instruments.14
In agreement with the United Nations Sustainable 
Development Goals to reduce premature mortality from 
NCDs by one- third through prevention and better treat-
ment by 2030, the Belgian Federal Government has prior-
itised the integrated care for chronically ill patients in 
order to increase patients’ quality of life, to improve the 
quality of care and to use the allocated resources more 
effectively.15 16 Knowledge about those diseases and predic-
tors with a greater impact on patients’ HRQoL as well as 
knowledge on the complex relationship between HRQoL 
and comorbidities can guide healthcare providers in their 
clinical practice and policy makers in their priority setting 
regarding screening, prevention and disease treatment.
The aim of this study is to provide insight in HRQoL 
outcomes and their predictors in patients with NCD, 
with a focus on multimorbidity and socioeconomic status 
in the context of a primary care setting. The outcomes 
of this study will estimate the relative effects of socio-
economic status and multimorbidity on HRQoL across 
different categories of NCDs. The following main study 
objectives can be defined:
Objective 1: this study wants to assess the impact of NCDs 
on patients’ HRQoL by identifying the key predictors 
associated with an impaired HRQoL and by allowing for 
comparison across different disease groups and socioeco-
nomic classes. In this study, there will be a special focus 
on socioeconomic status, due to its substantial impact on 
the healthy lifespan. In Belgium, the difference in the 
total number of healthy life years between highest and 
lowest educated persons amounts to 10.4 years in men 
and 13.5 years in women.17
Objective 2: this study wants to determine the impact 
of multimorbidity on HRQoL in patients with NCDs 
attending primary care.
METHODS
Study population and design
A primary care- based cross- sectional study was designed 
to investigate the association between NCDs and patients’ 
HRQoL in Flanders (Belgium). The study participants are 
adult patients (≥18 years) who are medically diagnosed 
(≥6 months) with at least one of the following diseases, in 
various degrees of severity: (1) cardiometabolic disorders; 
(2) mental disorders; or (3) musculoskeletal disorders. 
Any NCD that fits within the three disease groups can 
be included. The selection of these three disease groups 
was based on evidence confirming the lower HRQoL in 
all the above- mentioned disease groups compared with 
other diseases.18 Study participants with insufficient 
understanding of Dutch to complete the questionnaire 
or to give informed consent as well as study participants 
with a major cognitive impairment are excluded.
Sample size calculation
To achieve the research aims, multiple linear regression 
models will be conducted assessing several key predictors 
associated with HRQoL as primary outcome. The regres-
sion models should allow for controlling the effect of 
main confounders (eg, sex, age, educational attainment), 
and for including interaction terms with psychosocial vari-
ables. A sample size calculation showed that the minimum 
required sample for a multiple regression study including 
10 predictors with a medium anticipated effect size was 
118, given a desired statistical power level of 80% and a 
probability level of 5%.19–22 The sample size was increased 
with 50% to allow for testing interaction effects. This 
study has three clusters of disease groups (cardiometa-
bolic disorders, mental disorders and musculoskeletal 
disorders), therefore stratified analyses require a triple 
sample size. Hence, an a priori sample size of minimum 
531 participants is targeted. This sample size will also 
widely cover analysing clinically relevant differences 
between a number of chronic disease subgroups. Based 
on the conclusions of a systematic review by Norman et 
al, the clinically relevant difference will be set at half a SD 
which appears to be the threshold of discrimination for 
changes in HRQoL for NCDs.23 Using a statistical power 
level of 80% and a probability level of 5%, information 
on 76 patients per disease cluster is needed (1) to assess 
the HRQoL (based on SF-36) in each patients’ group with 
a 5% precision and (2) to allow for comparisons across 
groups.24–34
Recruitment of participants
Patient recruitment is organised through general practi-
tioners (GPs) with independent practices and GP practices 
within community health centres across all the provinces 
in Flanders. First, a number of GP practices located across 
urban and rural regions willing to participate in this study 
are identified through convenience sampling based on 
their contact with a so- called ‘local quality group’ (LOK 
group). A LOK group consists of fellow GPs who share 
and critically discuss their medical practices in order to 
improve the quality of care. The Flemish GP association 
(Domus Medica) disseminated a call asking whether LOK 
groups are interested in a presentation related to the 
subject of the study for a LOK group meeting. At these 
meetings, the researchers briefly present the study and 
they ask GPs willingness to cooperate in the study. GPs 
are asked to identify patients within their practice after 
validation of the eligibility criteria. GPs will explain briefly 
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the purposes of the study to the patients and invite them 
to participate through voluntary response sample. Inter-
ested GPs receive more detailed information to ensure 
the aim of the study and the data collection process are 
understood. To achieve the targeted sample size of 531 
participants, a minimum of 50 general practices, each 
distributing at least 20 questionnaires, is aimed for.
Data collection
A paper- based questionnaire is developed based on the 
literature and consists of diverse validated instruments. 
Expert reviews from GPs, academic researchers and 
epidemiologists were used to evaluate the questionnaire. 
The questionnaire was pilot tested by patients, from 
different age classes, diagnosed with a NCD in order to 
evaluate the feasibility of the questionnaire in terms of 
readability, comprehensibility and duration. The ques-
tionnaire, including informed consent, is distributed 
to the participant by the GP at consultation. Each ques-
tionnaire has a unique ID code. The questionnaire takes 
approximately 30 min to gather patient information and 
research outcomes and is filled in by the patient at home. 
Completed questionnaires can be returned by post via a 
prepaid return envelope, which is enclosed with all ques-
tionnaires. The questionnaire can also be given back to 
the GP at later consultation. The pathway for recruiting 
participants and data collection is illustrated in figure 1.
Reminder phone calls to the GPs take place every 
2 months. In order to motivate the GPs to distribute the 
Figure 1 Pathway for recruiting participants and data collection.
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questionnaires, the number of questionnaires already 
received from their practice is communicated. In addi-
tion, an individualised tri- monthly newsletter is sent to all 
GPs with an update of the current status of the study.
Research outcomes and instruments
The revised model of Wilson and Cleary is used as theo-
retical framework to measure HRQoL and its predictors 
in patients with NCDs (figure 2).35 First, information on 
the characteristics of the chronically ill patients and their 
environment are collected. Second, information on the 
five health concepts in patient outcomes are collected: 
biological function, symptoms, functional status, general 
health perceptions and overall HRQoL.36 37
Characteristics of chronically ill patients and their environment
Based on the ecological model of McLeroy et al, five levels 
of influencing factors are linked with the health concepts 
determining HRQoL, namely: intrapersonal factors, inter-
personal factors, institutional factors, community factors 
and public policy. The intrapersonal factors contain char-
acteristics of the individual (eg, sociodemographic char-
acteristics, personality traits, modifiable risk factors). The 
remaining four factors are identified as environmental 
characteristics.38
Sociodemographic characteristics
The following sociodemographic characteristics are gath-
ered: age, sex, region of residence (ie, Flanders, Brus-
sels or Wallonia), nationality, marital status, size of the 
household, educational attainment (ie, primary school, 
lower secondary education, higher secondary educa-
tion, higher education, doctoral degree), occupational 
status, income level and National Registration Number. 
The latter can track study participants in the National 
Register database providing information on possible 
death of the participants, which can be useful for future 
research.
Socioeconomic status
Socioeconomic status represents a core concept in this 
study because evidence indicates that socioeconomic 
deprivation is associated with worse HRQoL outcomes.39 40 
Socioeconomic status is a combined measure of an indi-
vidual’s social and economic position relative to others 
and commonly based on three main indicators: educa-
tional level, income level and occupational status.41 42 
Educational level will be measured as the highest level 
of education attained by the patient based on the Inter-
national Standard Classification of Education.43 Income 
level will be measured by asking patients’ monthly per 
capita household income (total net household income/
number of members). Occupational status will be based 
on the following categories: employed, unemployed and 
not in the work field (eg, pension, disability). These 
three indicators of socioeconomic status will be studied 
separately as the different measures give additional 
information.
Personality traits
Since research has confirmed that personality traits 
are related to various health outcomes, the interest in 
this field is growing.44 Different personality traits are 
measured using the short Big Five Inventory (BFI-10) to 
allow a quick assessment of a person’s degree of extra-
version, agreeableness, conscientiousness, emotional 
stability and intellect/openness.45 The BFI-10 is very brief 
and suitable for applications in large- scale surveys as it 
takes 1 min to complete. The instrument consists of 10 
items where each item is scored on a 5- point Likert scale 
ranging from ‘strongly disagree’ to ‘strongly agree’. The 
Dutch version has been demonstrated to be reliable and 
valid.45
Sense of coherence
During the last decades, several studies assessed the 
impact of sense of coherence on quality of life. These 
studies showed that stronger levels of sense of coherence 
Figure 2 The revised Wilson and Cleary model for health- related quality of life is used as theoretical framework.
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predict positive health outcomes and better overall 
quality of life.46–48 Evaluating sense of coherence is there-
fore of interest, especially in NCDs, in order to under-
stand why people under stress stay healthy, while others 
not.46 49 Sense of coherence is measured using the brief 
Antonovsky’s Sense of Coherence Scale (SOC), which 
contains 13 items covering three dimensions: compre-
hensibility (the extent to which events are perceived as 
making sense, that they are ordered, consistent and struc-
tured), manageability (the extent to which a person feels 
he/she can cope) and meaningfulness (how much one 
feels that life makes sense and challenges are worthy of 
commitment).49 Responses are reported by a semantic 
scale ranging from 1 (never or very seldom) to 7 (very 
often). SOC scores range from 13 to 91, and a higher 
score indicates higher SOC. The structural validity of the 
Dutch SOC-13 has been confirmed.50
Self-efficacy
Self- efficacy is the belief in one’s competence to attempt 
difficult or novel tasks and to cope with adversity arising 
from specific demanding situations.51 Higher levels of 
self- efficacy are related to an increase in the number 
of satisfying social relations, which may be beneficial to 
HRQoL outcomes.51 52 Since there is a lack of research 
investigating general self- efficacy and HRQoL among 
patients with NCD, this study assesses the relationship 
between both. General self- efficacy is measured using 
the Dutch version of the General Self- Efficacy Scale 
(GSES).53 54 The GSES is a 10- item psychometric scale 
that is designed to assess optimistic self- beliefs to cope 
with a variety of difficult demands in life. The total 
score is calculated by the sum of all items. Scores range 
between 10 and 40, with higher scores indicating more 
self- efficacy. The psychometric quality of the instrument 
is sufficient.53
Health literacy
Low health literacy levels are observed in the general 
population, and specifically in patients with NCDs.55–57 
In recent decades, evaluating individuals’ health literacy 
has received increased attention, as it is associated with 
numerous negative health outcomes, such as lower quality 
of life, but the relationship is still unclear. Therefore, a 
better understanding of the relationship between health 
literacy and HRQoL is necessary.55 The HLS- EU- Q6 is used 
as a short scale of the European Health Literacy Survey 
(HLS- EU- Q).58 This tool consists of six items addressing 
self- reported difficulties in accessing, understanding, 
appraising and applying information in tasks concerning 
decision- making in healthcare, disease prevention and 
health promotion.59 Responses are reported from 1 (very 
difficult) to 4 (very easy). The scale score varies between 1 
and 4, with higher scores indicating better health literacy. 
Correlations of the HLS- EU- Q6 with the index of the long 
scale HLS- EU- Q were high.60
Patient enablement
Research demonstrated that improvements in patient 
enablement may result in better quality of life.61 There-
fore, this study includes patient enablement as a 
predictor of HRQoL. The Patient Enablement Instru-
ment (PEI) focuses on the impact of a clinical consulta-
tion for an acute or chronic disease in primary care on 
a patient’s self- perceived ability to understand and cope 
with health issues and the disease itself. The PEI consists 
of six questions that reflect patient enablement.62 The 
responses are scored on a 3- point scale (‘same or less/not 
applicable’=0, ‘better/more’=1 and ‘much better/much 
more’=2). The total PEI score ranges between 0 and 12 to 
indicate low (0–4), medium (score 5–9) and high enable-
ment (10–12). A Dutch version was conducted by the 
researchers via forward- backward translation.
Modifiable risk factors for chronic diseases
This study collects information on risk factor prevalence 
by assessing the following items: current smoking status, 
alcohol consumption (quantities per week), leisure time 
physical activity (almost entirely sedentary, light physical 
activity, more vigorous physical activity, highly vigorous 
physical activity) and anthropometry (self- reported 
weight and height). The latter will be used to calculate 
body mass index (BMI). Participants with a BMI between 
25 and 29.9 kg/m2 will be considered overweight and 
participants with a BMI ≥30 will be considered obese.
Work ability
Three questions of the Work Ability Index (WAI) ques-
tionnaire are used. The WAI is used to assess work ability 
with questions about workers’ health status, their capabil-
ities and mental and physical demands of their work.63 64
Health care use
Patients who use primary care services more frequently 
have been reported to have lower HRQoL outcomes. 
Therefore, healthcare resource use is measured by the 
following items: number of hospitalisations/emergency 
room visits/specialist consultations in the last 6 months 
and number of GP consultations/other outpatient visits/
home help services (eg, nurse visits, home help visits, 
cleaning services) in the last month.
Pharmacological treatment
It is important to assess the influence of polypharmacy 
on HRQoL, especially in NCDs, given the increased risk 
of adverse health outcomes.65 Medication use is assessed 
with the question “Which medication are you currently 
taking?” Although there exists no universal definition, 
polypharmacy will be defined as the use of five or more 
medications concomitantly.66
Social environmental characteristics
The influence of social environmental characteristics 
(eg, interpersonal factors, social influences) on health 
outcomes is obtained by questioning social support and 
informal caregiving. Social support is measured using the 
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six- item shortened version of the Social Support Ques-
tionnaire (F- SozU) by Fydrich et al.67 68 This valid and 
reliable instrument is well accepted in epidemiological 
contexts to assess social support in the general popula-
tion. A Dutch version was conducted by the researchers 
via forward- backward translation. Responses are rated on 
a 5- point Likert scale, ranging from 1 (does not apply) 
to 5 (exactly applicable). The total range is from 0 to 30, 
with higher values representing higher perceived and 
received social support. Informal care is measured by the 
following items: number of informal caregivers, relation-
ship with the informal caregiver (eg, spouse, parent), how 
many days per week they receive informal care and tasks 
of the informal caregiver (eg, dressing, bathing).
Biological function
Biological functions encompass functioning of molecular, 
cellular and organ systems that can be analysed by labo-
ratory tests, physical assessment and medical diagnosis.35 
In this study, biological functions are restricted to the 
medical diagnosis documented via the participating GP.
Multimorbidity
Multimorbidity is measured by a self- developed list based 
on a multimorbidity questionnaire (MM-21), and docu-
ments 24 self- reported NCDs in primary care.69 Partici-
pants have to indicate for each condition ‘yes’ or ‘no’, 
‘yes’ may only be filled in for the conditions that have 
been confirmed by a doctor or for which the participant 
is taking prescribed drugs.69 Participants are also asked in 
which year the disease was diagnosed. To date, consensus 
on defining, assessing and measuring multimorbidity is 
still lacking as each method has its specific strengths and 
limitations. However, defining multimorbidity as the pres-
ence of two or more chronic diseases at the same time in 
one individual is not universally accepted, especially when 
highly prevalent conditions (eg, hypertension, osteopo-
rosis) are included as these result in higher prevalence 
rates.70 This study will therefore use a cut- off value of ≥3 
chronic disease to define multimorbidity. However, sensi-
tivity analyses will be conducted with other cut- off values.
Symptoms
Biological functions are directly linked with symptoms, 
which is the second patient outcome. Symptoms can be 
stated as a patient’s perception of an abnormal physical, 
emotional or cognitive state.35 This study uses a symptom- 
specific validated measure to assess non- physical symp-
toms: the Hospital Anxiety and Depression Scale 
(HADS).71 The HADS is a 14- item brief instrument to 
determine presence of anxiety and depressive states. The 
HADS compromises two scales, each consisting of seven 
items.71 72 A maximum score of 21 can be achieved per 
scale. The higher the overall score, the higher the levels 
of anxiety and depression.
Functional status
Functional status can be defined as ‘the ability of an indi-
vidual to perform specific tasks in multiple domains such 
as physical function, social function, role function and 
psychological function’, and can be measured by both 
objective and subjective (ie, self- perceived health status) 
instruments.37
Self-perceived health status
This study uses the 12- item Short Form Health Survey 
(SF-12) as a generic self- perceived health status instru-
ment to assess patients’ functional health and well- being by 
measuring both physical and mental functioning compo-
nents. In this study, the 12- item version instead of the 
36- item version is preferred as it can be easily completed 
in 5 min. The instrument contains 12 items including 
eight domains (physical functioning, role- physical, bodily 
pain, general health, vitality, social functioning, role- 
emotional and mental health). The summary scores, on a 
scale from 0 to 100, will be calculated to represent phys-
ical functioning and mental functioning. Higher scores 
indicate better self- perceived health status. The SF-12 has 
been confirmed as a valid and reliable instrument for 
measuring health perception in a general population for 
primary care.73 Moreover, a second generic instrument 
is used to measure one’s self- perceived health status, the 
EQ- 5D- 5L, which is composed of two parts: a descriptive 
system and a visual analogue scale (VAS). The descriptive 
system consists of five health- related domains (mobility, 
self- care, usual activities, pain/discomfort, anxiety/
depression) defined by five severity levels (no problems, 
slight problems, moderate problems, severe problems, 
extreme problems) from which an EQ- 5D index score, 
or utility score, can be calculated. A utility is defined on a 
scale anchored at 0 (death) and 1 (perfect health), and 
can represent negative values for health states perceived 
worse than death.74 The VAS provides a self- rating of the 
general health status on a scale from 0 (worst imaginable 
health) to 100 (best imaginable health). In this study, self- 
perceived health status is used as a proxy for HRQoL.
General health perceptions
General health perceptions are subjective ratings which 
combine all the previous health concepts and can be 
measured with a single global question, asking people 
to rate their health ranging from poor to excellent. This 
study uses the SF-12 which has this single item incorpo-
rated by the following question: “In general, would you 
say your health is excellent/very good/fair/poor?”
Illness perception
Research confirms that positive illness perceptions 
are related to better quality of life.75 76 This study aims 
to determine whether illness perceptions differ across 
NCDs and clusters thereof. The Dutch version of the 
brief Illness Perception Questionnaire (IPQ- B) is used 
for assessing patients’ cognitive and emotional represen-
tations of their illness including consequences, timeline, 
personal control, treatment control, identity, coherence, 
concern, emotional response and causes.77 78 The ques-
tionnaire uses a scale from 0 to 10 to assess cognitive 
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illness representations (item 1–5), emotional representa-
tions (item 6 and 8) and illness comprehensibility (item 
7). A low score on items number 1, 2, 5, 6 and 8 indicates 
that the illness is perceived as benign while a low score on 
the items 3, 4 and 7 indicates that the illness is perceived 
as threatening. By reversing these three items it is possible 
to compute an overall score. A higher score reflects a 
more threatening view of the illness. The reliability and 
validity of the IPQ- B are supported in different chronic 
illness populations.77 The face and content properties of 
the Dutch version were found to be acceptable.79
The conceptual HRQoL model of Wilson and Cleary 
represents the relationships between the multiple 
outcomes. It is hypothesised that the following outcomes 
would have an adverse effect on patients' HRQoL: patients 
who have multiple conditions, patients who perceive high 
levels of anxiety/depression and patients who perceive 
lower functional ability. Moreover, we expect that the 
following outcomes would result in lower HRQoL expe-
rienced by patients with NCD: lower socioeconomic 
status, high risk factor prevalence (smoking, high alcohol 
consumption, high BMI), maladaptive coping, frequent 
healthcare use, polypharmacy, limited social support, 
negative illness perceptions and lower levels of self- 
efficacy, sense of coherence, patient enablement and 
health literacy.
Statistical methods
Descriptive statistics will be performed in order to describe 
the sample of study participants. For normally distributed 
continuous variables, means and SD will be calculated, for 
non- normally distributed continuous variables, medians 
and IQRs will be calculated. If normally distributed, inde-
pendent sample T- tests for continuous variables and χ2 tests 
for categorical variables will be used to compare character-
istics of the study participants. Non- parametric tests will be 
used when variables are not normally distributed.
Multiple linear and logistic regression models will be built 
assessing the key predictors associated with HRQoL as main 
outcome parameter, adjusted for possible confounding 
variables (sex, age, educational attainment, health- related 
risk behaviour, symptom status). Different substudies will 
be conducted and for each substudy different models will 
be built, assessing crude and adjusted relations between 
predictor variables and HRQoL. The primary analysis will 
include an indicator variable for NCD category, socio-
economic status, marital status, presence of comorbidity, 
anxiety/depression, social support, sense of coherence and 
self- efficacy as independent variables. Interactions between 
NCD categories and other key variables (eg, socioeconomic 
status) will be tested. In case of interaction (p- value <0.10 
for the interaction term), stratification per NCD group will 
be conducted.
Given the exploratory nature of the study, advanced 
mediation analysis testing for specific causal pathways will 
not be performed. Multicollinearity will be assessed when 
building multiple regression models, excluding variables in 
case they correlate extensively (eg, Pearson’s r ≥0.60) with 
others. The statistical analyses will be performed using IBM 
SPSS statistics and a p- value of 0.05 will be considered as 
statistically significant. Each model will be corrected for 
multiple testing, using the Bonferroni method, since there 
are two outcome variables for HRQoL.
PATIENT AND PUBLIC INVOLVEMENT
Neither patients nor the public were involved in the 
design of the study. Patients were invited to pilot test the 
paper- based questionnaire in order to evaluate the feasi-
bility of the questionnaire in terms of readability, compre-
hensibility and duration.
DISCUSSION
The main strength of this study is its contribution to the 
necessity for evidence on key predictors associated with 
an impaired HRQoL in patients with NCD. The results 
can support patient management of (multiple) NCDs 
within the primary care setting, which is of major interest 
to healthcare providers and policy makers in national and 
international context.
A methodological strength of this study is the use of 
objective medical diagnoses, which limits the risk of self- 
reported bias. In this way, our study distinguishes from other 
studies often including self- reported medical diagnosis, for 
example, the Belgian Health Interview Survey.80 Another 
strength is the use of international, validated instruments 
to assess HRQoL and its predictors. Regarding the former, 
this study includes two different instruments (EQ- 5D- 5L 
and SF-12) to evaluate HRQoL, and could therefore 
compare the results of both instruments. Furthermore, the 
sample size includes participants from all age categories 
(≥18 years) while many studies focus on older populations, 
since chronic diseases are more prevalent in the elderly.81 82 
Another strength is that the questionnaire has been pilot 
tested by patients of interest to improve the feasibility of 
the questionnaire. A final strength is that this study is devel-
oped to minimise time investment for GPs in order to maxi-
mise GP recruitment rates.
Several limitations need to be taken into account. 
First, this study has a cross- sectional study design and 
could therefore not detect causal relationships. Second, 
recruitment of patients follows a voluntary response 
procedure, which is vulnerable to sampling bias due to 
a high non- response rate and results in a less represen-
tative sample population.83 Women, older individuals 
and individuals with higher educational attainment will 
likely be over- represented in our sample as they are 
more prone to return postal questionnaires.84 85 More-
over, the prevalence of health- related risk behaviour (eg, 
smoking, alcohol consumption, physical inactivity) as well 
as impaired health status may be underestimated due 
to selective non- response effects and social desirability 
bias.86 87 In response to the possible selection bias, an 
additional qualitative study based on in- depth face- to- face 
interviews will be initiated in difficult- to- reach patients 
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(eg, lower socioeconomic status, more severe illness) 
to allow further investigation of the impact of NCDs on 
these patients’ HRQoL.86
This cross- sectional study will improve the under-
standing of the key predictors of self- perceived health 
status in patients with NCDs, and particularly provide 
new insights in multimorbidity. The knowledge gained is 
necessary to improve the quality of care in primary care, 
to support patients’ self- management and to allocate 
resources more effectively.
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The study has been designed according to the principles of 
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